Novel 2-phenyl-6-phenylethynyl-4-(trifluoromethyl)quinolines: Synthesis by Sonogashira cross-coupling reaction and their evaluation as liquid crystals
-
Add time:07/13/2019 Source:sciencedirect.com
This work reports the synthesis of a new series of 2-aryl-6-(phenylethynyl)-4-(trifluoromethyl) quinolines (2), where aryl = 4-(phenylethynyl)phenyl (2a), Ph (2b), 4-MeC6H4 (2c), 4-FC6H4 (2d). These were obtained by the Sonogashira coupling reaction producing 42–88% yield, utilizing 6-bromoquinolines and phenylacetylene as precursors in the presence of catalyst systems of Pd(OAc)2 and PPh3. The precursor 6-bromoquinolines were obtained from an intramolecular cyclisation reaction of (Z)-4-[(4-bromophenyl)amino]-1,1,1-trifluorobut-3-en-2-ones, which were previously prepared though the reaction of 4-methoxy-4-aryl-1,1,1-trifluoroalk-3-en-2-ones with 4-bromoaniline. Liquid crystal (LCs) properties were evaluated using thermal data and mesophase texture. Only compound 2a displayed monotropic nematic mesophase with very narrow liquid crystal window. Compounds 2b, 2c and 2d only displayed transition between the crystal phase to a liquid state. Nematic behavior was mainly dependent on the molecular length, as proved for 2a, which has the longest molecular length. Torsional angles between quinoline and aryl moieties at the 2-position were significant on hysteresis observed during the crystallization process.
We also recommend Trading Suppliers and Manufacturers of 4-(2-Amino-4-bromophenyl)-2-piperazinone (cas 1016845-08-1). Pls Click Website Link as below: cas 1016845-08-1 suppliers
Prev:Experimental and theoretical characterization of organic salt: 2-((4-bromophenyl)amino) pyrido[1,2-a] quinoxalin-11-ium bromide monohydrate synthesized via oxidative cyclization
Next:Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Regioselective cyclometallation of N-methyl-N-(naphthalen-2-ylmethyl)-2-(pyridin-2-yl)ethanamine with palladium(II) acetate and catalytic reduction of various functional groups07/16/2019
- Synthesis and structure–activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists07/15/2019
- Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)07/14/2019
- Experimental and theoretical characterization of organic salt: 2-((4-bromophenyl)amino) pyrido[1,2-a] quinoxalin-11-ium bromide monohydrate synthesized via oxidative cyclization07/12/2019
- Assembly and weak interactions in the crystal structure of 2-amino-4-(3-bromophenyl)-1,3,5-triazinobenzimidazolium chloride studied by X-ray diffraction, vibrational spectroscopy, Hirshfeld surface analysis and DFT calculations07/11/2019


